Abstract Library

#4436 Application of novel wound materials in symptom management of patients with neuroendocrine tumours

Introduction: Neuroendocrine tumours can occur in multiple parts of the body, and management faces challenges.

Conference:

Presenting Author:

Authors: Liu G, Gu T, Tang Y, Xie W, Zhu Y,

Keywords: neuroendocrine tumour, novel wound materials, symptom management,

#4062 Incidence patterns and clinical implications of venous thromboembolism (VTE) in patients (pts) with neuroendocrine neoplasms (NEN)

Introduction: VTE is a significant complication in oncology and one of the primary causes of cancer-related mortality. Few studies have addressed VTE in pts with NEN, with an estimated incidence of 7.5% in the literature. Nevertheless, there is no evidence from large datasets.

Conference:

Presenting Author:

Authors: Hernando Cubero J, Gutierrez-Gordo M, Roca-Herrera M, García-Álvarez A, Serradell S,

Keywords: Thrombosis, Heparin, Splenic thrombosis,

#3379 Survey of neuroendocrine tumor patients’ experience of quality of care provided by a dedicated NET Dietitian

Introduction: The Birmingham Neuroendocrine Tumour (NET) service has a full time dedicated NET Dietitian for outpatient and inpatient care since August 2020.

Conference:

Presenting Author: Mair R

Authors: Mair R, Bradley E, Davis N, Shah T,

Keywords: net, DIETITIAN, QUALITY OF LIFE, SYMPTOM CONTROL,

#3354 Cancer associated fibroblasts induce proliferation and therapeutic resistance in neuroendocrine tumors through STAT3 activation

Introduction: Cancer-associated fibroblasts (CAF) have been identified as relevant contributors to cancer progression and drug resistance in many tumors. Although neuroendocrine tumors (NET) are often associated with a strong stromal reaction, no study has addressed whether CAF are involved in progression and therapeutic resistance in NET.

Conference:

Presenting Author:

Authors: Amin T, Viol F, Fahl M, Eggers C, Awwad F,

Keywords: neuroendocrine tumor, cancer associated fibroblasts, NT-3, cell lines,

#3166 Aberrant expression pattern of circadian clock genes in type 1 gastric neuroendocrine neoplasms compared to ECL-cell hyperplasia

Introduction: There is a continuity of changes from ECL-cell hyperplasia to type 1 gastric neuroendocrine neoplasms (GNEN1) development with important clinical implications.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Daskalakis K

Authors: Karapanagioti A, Daskalakis K, Nasiri-Ansari N, Vlachou E, Kyriakopoulos G,

Keywords: GNEN1, ECL-cell hyperplasia, CLOCK genes, circadian rythmicity,